WILMINGTON, Del., April 04, 2018 -- Navient (Nasdaq:NAVI), a leading asset management and business processing services company, today received a notice of Schedule 13D filing by Canyon Capital Advisors and released the following statement:
Navient values Canyon’s investment and interest in our company. We regularly have discussions with shareholders, and will engage with Canyon to discuss potential board nominees and to continue to learn more about their ideas toward our common goal of enhancing shareholder value.
About Navient
Navient (Nasdaq:NAVI) is a leading provider of asset management and business processing solutions for education, healthcare and government clients at the federal, state and local levels. The company helps its clients and millions of Americans achieve financial success through services and support. Headquartered in Wilmington, Delaware, Navient employs team members in western New York, northeastern Pennsylvania, Indiana, Tennessee, Texas, Virginia, Wisconsin and other locations. Learn more at navient.com.
Contact:
Media: Patricia Nash Christel, 302-283-4076, [email protected]
Investors: Joe Fisher, 302-283-4075, [email protected]
NAVICF


Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 



